<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Jenscare Scientific Co Ltd — News on 6ix</title>
<link>https://6ix.com/company/jenscare-scientific-co-ltd</link>
<description>Latest news and press releases for Jenscare Scientific Co Ltd on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 30 Oct 2025 01:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/jenscare-scientific-co-ltd" rel="self" type="application/rss+xml" />
<item>
<title>Jenscare released its multi-product portfolio's, including LuX-Valve Plus TRINITY study, JensClip and Ken-Valve, remarkable clinical outcomes at TCT 2025 in the U.S.</title>
<link>https://6ix.com/company/jenscare-scientific-co-ltd/news/jenscare-released-its-multi-product-portfolios-including-lux-valve-plus-trinity-study-jensclip-and-ken-valve-remarkable-clinical-outcomes-at-tct-2025-in-the-us</link>
<guid isPermaLink="true">https://6ix.com/company/jenscare-scientific-co-ltd/news/jenscare-released-its-multi-product-portfolios-including-lux-valve-plus-trinity-study-jensclip-and-ken-valve-remarkable-clinical-outcomes-at-tct-2025-in-the-us</guid>
<pubDate>Thu, 30 Oct 2025 01:00:00 GMT</pubDate>
<description>Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company, recently released 6-month follow-up results of TRINITY Trial of LuX-Valve Plus, a promising self-developed TTVR system, and 1-year outcomes and challenging cases of JensClip and Ken-Valve, a proprietary TMVr system and TAVR (AR) system respectively, representing the Company's diversified and high-potential multi-product portfolio, at TCT 2025 in the U.S..</description>
</item>
<item>
<title>LuX-Valve Plus Approved for Hong Kong-Macao Medicine and Equipment Connect</title>
<link>https://6ix.com/company/jenscare-scientific-co-ltd/news/lux-valve-plus-approved-for-hong-kong-macao-medicine-and-equipment-connect</link>
<guid isPermaLink="true">https://6ix.com/company/jenscare-scientific-co-ltd/news/lux-valve-plus-approved-for-hong-kong-macao-medicine-and-equipment-connect</guid>
<pubDate>Thu, 09 Oct 2025 13:00:00 GMT</pubDate>
<description>Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company with comprehensive structural heart disease interventional solutions, recently announced that LuX-Valve Plus transjugular tricuspid valve replacement system, the product of its subsidiary Jenscare Scientific (Netherlands) B.V., has been officially approved to be included in the Medical Device Catalog of Hong Kong-Macao Medicine and Equipment Connect, enabling commercial clinical applica</description>
</item>
<item>
<title>Jenscare, releases 2025H1 interim results</title>
<link>https://6ix.com/company/jenscare-scientific-co-ltd/news/jenscare-releases-2025h1-interim-results</link>
<guid isPermaLink="true">https://6ix.com/company/jenscare-scientific-co-ltd/news/jenscare-releases-2025h1-interim-results</guid>
<pubDate>Mon, 01 Sep 2025 05:00:00 GMT</pubDate>
<description>Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company with TTVR breakthroughs, achieved milestones in its product portfolio globally, and just released its interim results for 2025H1 ended June 30, 2025.</description>
</item>
<item>
<title>Jenscare Announces 2025H1 Interim Results</title>
<link>https://6ix.com/company/jenscare-scientific-co-ltd/news/jenscare-announces-2025h1-interim-results</link>
<guid isPermaLink="true">https://6ix.com/company/jenscare-scientific-co-ltd/news/jenscare-announces-2025h1-interim-results</guid>
<pubDate>Mon, 01 Sep 2025 01:00:00 GMT</pubDate>
<description>Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company dedicated to interventional treatment for structural heart diseases, achieved key milestones in its product portfolio and just announced its interim results for 2025H1.</description>
</item>
<item>
<title>Jenscare released 30-day follow-up results of LuX-Valve Plus TRINITY study and 1-year follow-up results of JensClip TMVr at EuroPCR 2025</title>
<link>https://6ix.com/company/jenscare-scientific-co-ltd/news/jenscare-released-30-day-follow-up-results-of-lux-valve-plus-trinity-study-and-1-year-follow-up-results-of-jensclip-tmvr-at-europcr-2025</link>
<guid isPermaLink="true">https://6ix.com/company/jenscare-scientific-co-ltd/news/jenscare-released-30-day-follow-up-results-of-lux-valve-plus-trinity-study-and-1-year-follow-up-results-of-jensclip-tmvr-at-europcr-2025</guid>
<pubDate>Tue, 03 Jun 2025 01:00:00 GMT</pubDate>
<description>Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company, recently released 30-day follow-up results of TRINITY Trial of LuX-Valve Plus, a promising self-developed TTVR system, and 1-year outcomes of JensClip, a proprietary TMVr system, at EuroPCR 2025 in Paris, France.</description>
</item>
<item>
<title>Jenscare, with innovative TTVR and approved TAVR, releases 2024 annual results</title>
<link>https://6ix.com/company/jenscare-scientific-co-ltd/news/jenscare-with-innovative-ttvr-and-approved-tavr-releases-2024-annual-results</link>
<guid isPermaLink="true">https://6ix.com/company/jenscare-scientific-co-ltd/news/jenscare-with-innovative-ttvr-and-approved-tavr-releases-2024-annual-results</guid>
<pubDate>Tue, 25 Mar 2025 11:00:00 GMT</pubDate>
<description>Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company with TTVR breakthroughs and is entering commercialization stage for its TAVR (AR) product, released its annual results for year ended December 31, 2024.</description>
</item>
</channel>
</rss>